Detailed answers about NEWCELLS BIOTECH LIMITED, including incorporation, status, business activity, and accounts information.
When was NEWCELLS BIOTECH LIMITED founded?
NEWCELLS BIOTECH LIMITED was officially incorporated on 15 January 2015 and is registered under company number 09389592. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEWCELLS BIOTECH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEWCELLS BIOTECH LIMITED?
NEWCELLS BIOTECH LIMITED's current status is In Administration. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEWCELLS BIOTECH LIMITED do?
NEWCELLS BIOTECH LIMITED operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is NEWCELLS BIOTECH LIMITED's registered address?
The registered office address of NEWCELLS BIOTECH LIMITED is 11TH FLOOR LANDMARK ST PETER'S SQUARE, 1 OXFORD STREET, MANCHESTER, M1 4PB. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEWCELLS BIOTECH LIMITED financially stable?
The most recent accounts for NEWCELLS BIOTECH LIMITED were made up to 31 January 2025, filed as SMALL. Next accounts are due by 31 October 2026.
Does NEWCELLS BIOTECH LIMITED have any charges or mortgages?
NEWCELLS BIOTECH LIMITED has 2 registered charges, of which 1 is outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.